Abstract
Background. Increased formation of reactive oxygen species may be caused by the ion release of the metal alloys used in prosthetic dental restorations due to corrosion process. Isoprostanes, as products of lipid peroxidation, can be used as a marker for oxidative stress in the body. There are two big advantages of using isoprostanes as oxidative stress marker – presence in all fluids in the body and low reactivity. Saliva provides non-invasive, painless, and cost-effective sample collection and can be used as an alternative testing medium of blood and urine. Methods. This study presents the development and validation of a sample LC-MS/MS method for quantification of 8-isoprostaglandin F2-α in human saliva using salt-out assisted liquid-liquid extraction (SALLE). Results. The selected sample preparation procedure optimized chromatographic separation and mass detection provided high recovery and sensitivity of the analysis. The calibration curve was obtained in the predefined range 25 – 329 ng/L with R2 larger than 0.995. Normalized matrix varied between 89.7 % and 113.5%. The method showed sufficient accuracy and precision - accuracy in the range 89.7 % – 113.9 %, and precision between 2.3% and 5.4%. Conclusion. The proposed method is validated according to current EMA/FDA industrial guidance for bioanalysis and offers an appropriate level of sensitivity as well as sufficient accuracy and precision.
Keywords
Array
Array
Array
Array
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.